Mereo BioPharma (MREO) Asset Utilization Ratio (2023 - 2025)

Mereo BioPharma (MREO) has 3 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2025.

• Asset Utilization Ratio for Q4 2025 came in at 0.01, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01 (changed N/A YoY), and the FY2025 annual result was 0.01, changed N/A from the prior year.
• Asset Utilization Ratio advanced to 0.01 in Q4 2025 per MREO's latest filing, from 0.01 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.16 in Q1 2024 and troughed at 0.01 in Q2 2025.
• A 3-year average of 0.05 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
• On a YoY basis, Asset Utilization Ratio climbed as much as 20.47% in 2025 and fell as far as 41.94% in 2025.
• A 3-year view of Asset Utilization Ratio shows it stood at 0.12 in 2023, then slumped by 90.81% to 0.01 in 2024, then fell by 7.12% to 0.01 in 2025.
• Business Quant data shows MREO's Asset Utilization Ratio at 0.01 in Q4 2025, 0.01 in Q3 2025, and 0.01 in Q2 2025.